UNSPSC 51132202: Acetaminophen/aluminum hydroxide/aspirin/caffeine/magnesium hydr

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51132202 Acetaminophen/aluminum hydroxide/aspirin/caffeine/magnesium hydroxide is a Commodity code under which state and local governments procure finished pharmaceutical and over-the-counter (OTC) products, including combination analgesics and branded pain relief formulations, for distribution through public health agencies, multistate cooperative purchasing networks, and community health programs. Recent solicitations show state health agencies and county health departments purchasing naloxone and safe drug deactivation systems, generic multi-source pharmaceuticals, and OTC products through formal competitive bidding processes. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate purchasing cooperatives serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and participating states). The code captures both direct procurement by individual counties and coordinated purchasing across state and local networks for pharmaceutical distribution.

Geographic activity centers on Florida, Texas, and the upper Midwest, with Seminole County's naloxone procurement (IFB 60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas HHS Commission issued a Request for Information (RFI HHS0017013, posted April 3, 2026) to explore direct-to-manufacturer pharmaceutical prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's cooperative purchasing program (MMCAP S1070000015802, due March 26, 2026) sought generic multi-source pharmaceuticals and OTC products through multiple contracts distributed via three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), with awards effective July 1, 2026, and a two-year initial contract term. Price competitiveness weighs heavily in evaluation (75 percent in the MMCAP procurement), and vendors must maintain FDA compliance, cGMP certification, and contractual relationships with authorized distributors where required.